APA Alıntı

Pean, E., Demolis, P., Moreau, A., Hemmings, R. J., O'Connor, D., Brown, D., . . . Pignatti, F. (2012). The European Medicines Agency Review of Cabazitaxel (Jevtana®) for the Treatment of Hormone-Refractory Metastatic Prostate Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use. AlphaMed Press.

Chicago Stili Alıntı

Pean, Elias, Pierre Demolis, Alexandre Moreau, Robert James Hemmings, Daniel O'Connor, David Brown, Terry Shepard, Eric Abadie, ve Francesco Pignatti. The European Medicines Agency Review of Cabazitaxel (Jevtana®) for the Treatment of Hormone-Refractory Metastatic Prostate Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use. AlphaMed Press, 2012.

MLA Alıntı

Pean, Elias, et al. The European Medicines Agency Review of Cabazitaxel (Jevtana®) for the Treatment of Hormone-Refractory Metastatic Prostate Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use. AlphaMed Press, 2012.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..